Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1988 1
1989 2
1991 3
1992 1
1993 1
1994 1
1995 6
1996 7
1997 3
1998 5
1999 3
2000 1
2001 4
2002 1
2003 3
2004 3
2005 3
2006 4
2007 3
2008 4
2009 2
2010 4
2011 3
2012 5
2013 2
2014 4
2015 2
2016 2
2017 5
2018 4
2019 7
2020 4
2021 3
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

101 results
Results by year
Filters applied: . Clear all
Page 1
Syndrome of the trephined: When bone becomes the cure.
Ged C, Samson E, Riffaud L. Ged C, et al. Neurochirurgie. 2022 Oct;68(5):544-545. doi: 10.1016/j.neuchi.2022.01.003. Epub 2022 Mar 5. Neurochirurgie. 2022. PMID: 35260279 No abstract available.
Phlebotomy as an efficient long-term treatment of congenital erythropoietic porphyria.
Mirmiran A, Poli A, Ged C, Schmitt C, Lefebvre T, Manceau H, Daher R, Moulouel B, Peoc'h K, Simonin S, Blouin JM, Deybach JC, Nicolas G, Puy H, Richard E, Gouya L. Mirmiran A, et al. Among authors: ged c. Haematologica. 2021 Mar 1;106(3):913-917. doi: 10.3324/haematol.2019.228270. Haematologica. 2021. PMID: 31919078 Free PMC article. No abstract available.
CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations.
Cullot G, Boutin J, Toutain J, Prat F, Pennamen P, Rooryck C, Teichmann M, Rousseau E, Lamrissi-Garcia I, Guyonnet-Duperat V, Bibeyran A, Lalanne M, Prouzet-Mauléon V, Turcq B, Ged C, Blouin JM, Richard E, Dabernat S, Moreau-Gaudry F, Bedel A. Cullot G, et al. Among authors: ged c. Nat Commun. 2019 Mar 8;10(1):1136. doi: 10.1038/s41467-019-09006-2. Nat Commun. 2019. PMID: 30850590 Free PMC article.
CRISPR-Cas9 globin editing can induce megabase-scale copy-neutral losses of heterozygosity in hematopoietic cells.
Boutin J, Rosier J, Cappellen D, Prat F, Toutain J, Pennamen P, Bouron J, Rooryck C, Merlio JP, Lamrissi-Garcia I, Cullot G, Amintas S, Guyonnet-Duperat V, Ged C, Blouin JM, Richard E, Dabernat S, Moreau-Gaudry F, Bedel A. Boutin J, et al. Among authors: ged c. Nat Commun. 2021 Aug 13;12(1):4922. doi: 10.1038/s41467-021-25190-6. Nat Commun. 2021. PMID: 34389729 Free PMC article.
[Interest of UGT1A1 genotyping within digestive cancers treatment by irinotecan].
Boyer JC, Etienne-Grimaldi MC, Thomas F, Quaranta S, Picard N, Loriot MA, Poncet D, Gagnieu MC, Ged C, Broly F, Le Morvan V, Bouquié R, Gaub MP, Philibert L, Ghiringhelli F, Le Guellec C. Boyer JC, et al. Among authors: ged c. Bull Cancer. 2014 Jun;101(6):533-53. doi: 10.1684/bdc.2014.1933. Bull Cancer. 2014. PMID: 24977443 Review. French.
Identification of a novel alpha1-antitrypsin variant.
de Seynes C, Ged C, de Verneuil H, Chollet N, Balduyck M, Raherison C. de Seynes C, et al. Among authors: ged c. Respir Med Case Rep. 2016 Nov 18;20:64-67. doi: 10.1016/j.rmcr.2016.11.008. eCollection 2017. Respir Med Case Rep. 2016. PMID: 28053854 Free PMC article.
Xeroderma pigmentosum in South Africa: Evidence for a prevalent founder effect.
Kgokolo M, Morice-Picard F, Rezvani HR, Austerlitz F, Cartault F, Sarasin A, Sathekge M, Taieb A, Ged C. Kgokolo M, et al. Among authors: ged c. Br J Dermatol. 2019 Nov;181(5):1070-1072. doi: 10.1111/bjd.18030. Epub 2019 Jul 24. Br J Dermatol. 2019. PMID: 31017654 No abstract available.
101 results